November 11 (SeeNews) - The net profit of Romanian state-controlled drug maker Antibiotice [BSE:ATB] rose 22% year-on-year in the first nine months of 2016, reaching 18 million lei ($4.3 million/3.9 million euro), the company said on Friday.